Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?

A list of top biotech penny stocks includes Biomea Fusion, Inc. (NASDAQ:BMEA), a company developing treatments for cancers and metabolic diseases. Despite setbacks, BMEA shows potential for growth with a 353.86% price target increase.